Valuation: GC Genome Corporation

Market Cap 23TCr 17Cr 15Cr 14Cr 13Cr 24Cr 1.64TCr 25Cr 171.91Cr 68Cr 861.3Cr 65Cr 64Cr 2.72TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 17Cr 1L 1L 1L 95.94T 2L 1.22Cr 2L 12.74L 5L 63.83L 5L 5L 2.01Cr EV / Sales 2026 *
4.36x
EV / Sales 2027 * 3.29x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-3.39%
1 week+5.09%
Current month+12.01%
1 month+18.58%
3 months+90.94%
6 months+18.73%
Current year+42.23%
1 week 8,720
Extreme 8720
10,350
1 month 8,120
Extreme 8120
10,480
Current year 4,100
Extreme 4100
10,480
1 year 4,100
Extreme 4100
10,480
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/06/25 Free

Chief Executive Officer

1,69,285 -
17/06/25 Free 1,38,250 --
Change 5-day change 1-year change 3-year change Capi.($)
-3.39%+5.09%+33.24% - 17Cr
-1.07%+1.20%+14.09%+35.52% 12TCr
+0.37%+2.22%+4.92%+103.82% 10TCr
+0.64%+2.67%+109.83%+890.32% 5.82TCr
+1.75%+2.27%-5.92%+83.08% 2.91TCr
-0.57%+2.93%+32.78%+95.74% 2.66TCr
-0.30%+3.46%+17.70%+65.59% 2.67TCr
-0.81%+0.45%+27.60%+378.95% 2.16TCr
+1.48%-4.05%-22.32%-8.19% 1.96TCr
-0.68%+2.72%+3.48%+85.69% 1.89TCr
Average -0.26%+1.19%+21.54%+192.28% 4.22TCr
Weighted average by Cap. -0.06%+1.65%+23.66%+196.76%

Financials

2026 *2027 *
Net sales 3.9TCr 2.94Cr 2.63Cr 2.43Cr 2.2Cr 4.12Cr 279.46Cr 4.19Cr 29Cr 12Cr 146.42Cr 11Cr 11Cr 461.62Cr 4.88TCr 3.68Cr 3.29Cr 3.04Cr 2.75Cr 5.15Cr 349.69Cr 5.24Cr 37Cr 14Cr 183.21Cr 14Cr 14Cr 577.62Cr
Net income - -
Net Debt -5.94TCr -4.48Cr -4Cr -3.7Cr -3.35Cr -6.27Cr -425.64Cr -6.38Cr -45Cr -18Cr -223.01Cr -17Cr -16Cr -703.09Cr -6.88TCr -5.19Cr -4.64Cr -4.28Cr -3.88Cr -7.26Cr -493Cr -7.38Cr -52Cr -20Cr -258.3Cr -19Cr -19Cr -814.35Cr
Projected Income Statement - Annual - GC Genome Corporation
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
23/26/23 ₩9,700.00 -3.39% 6,87,441
22/26/22 ₩10,040.00 +1.11% 9,07,081
21/26/21 ₩9,930.00 -3.12% 5,80,228
20/26/20 ₩10,250.00 +9.63% 14,67,784
19/26/19 ₩9,350.00 +1.30% 7,03,731

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - GC Genome Corporation
  1. Stock Market
  2. Stocks
  3. A340450 Stock